Also known as: 1910 Genetics
Multimodal AI Platform for Modality Agnostic Drug Discoveryβ’
Company is active
Event Year: 2021
Company is active
Event Year: 2021
1910 is an AI-driven biotechnology company at the forefront of pharmaceutical innovation. We are uniquely positioned to accelerate the discovery of both small and large molecule therapeutics. Our approach leverages the integration of extensive multimodal data, cutting-edge artificial intelligence models, and high-throughput laboratory automation. This comprehensive infrastructure enables AI-powered drug discovery, streamlining the process and enhancing the potential for groundbreaking treatments.
1910 is an AI-driven biotechnology company at the forefront of pharmaceutical innovation. We are uniquely positioned to accelerate the discovery of both small and large molecule therapeutics. Our approach leverages the integration of extensive multimodal data, cutting-edge artificial intelligence models, and high-throughput laboratory automation. This comprehensive infrastructure enables AI-powered drug discovery, streamlining the process and enhancing the potential for groundbreaking treatments.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2019
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2019
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 20
Hiring: No
Team size: 20
Hiring: No